Disclosed positions

Estimated from their latest filings — positions may have changed since

$546.5K

combined est. value

Stock	Shares	Price	Value	Weight	As of
RZLTRezolute, Inc.	58,576	$4.68	$274.1K	50%	2025-11-19
XERSXeris Biopharma Holdings, Inc.	33,582	$8.11	$272.4K	50%	2026-07-01

RZLT

Rezolute, Inc.

$274.1K

58,576 sh

XERS

Xeris Biopharma Holdings, Inc.

$272.4K

33,582 sh

Activity

Open-market buy & sell volume

BuySell

Total +$10.0K bought

Most bought

RZLT

$10.0K

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 1sells 0

Stock	Transaction	Date	~6mo later
XERSXeris Biopharma Holdings, Inc.	Grant — · 33,582 sh	2026-07-01	—
RZLTRezolute, Inc.	Grant — · 21,000 sh	2025-11-19	—
RZLTRezolute, Inc.	Buy $10.0K · 3,076 sh	2025-06-13	+131.0%
RZLTRezolute, Inc.	Grant — · 9,000 sh	2025-06-10	—

XERSGrant

2026-07-01 · Xeris Biopharma Holdings, Inc.

33,582

—

RZLTGrant

2025-11-19 · Rezolute, Inc.

21,000

—

RZLTBuy

2025-06-13 · Rezolute, Inc.

$10.0K

+131.0%

RZLTGrant

2025-06-10 · Rezolute, Inc.

9,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.